BREAKING RESEARCH NEWS: Stem-Cell Generated Thymus Tissue to Catalyze New Treatments for Transplantation, Type 1 Diabetes and Other Autoimmune Diseases
UCSF Diabetes Center researchers Matthias Hebrok, PhD, and Mark Anderson, MD, PhD, have created in their labs the first functioning human thymus tissue derived from embryonic stem cells – a huge step forward in producing new cell therapies to treat numerous diseases including type 1 diabetes.
UCSF Diabetes Center offers intervention clinical trials for people with type 1 diabetes, as well as prevention studies for relatives of type 1 diabetes patients. Take the type 1 diabetes online screener to see if you or family members are eligible. More information HERE.
UCSF endocrinologist Umesh Masharani and his colleagues have dispelled a commonly held belief that chromium supplements improve insulin sensitivity and help prevent and treat diabetes.
Diabetes Center investigator Suneil Koliwad, MD, PhD, is exploring how nutritional factors may stimulate tissue inflammation and increase the risk for developing type 2 diabetes. Dr.
Center Director Matthias Hebrok, PhD, and his lab colleagues have optimized existing culture conditions to increase the number of pancreas progenitor cells and insulin-producing cells from human stem cells. Their current studies indicate that they are getting closer to generating functional beta cells for transplantation purposes.
With two type 1 diabetes prevention trials currently underway, it is important for blood relatives of those with type 1 diabetes to be tested for autoantibodies that may predict future onset of disease. <TrialNet Information for Relatives>
We'd like to introduce you to a new member of the Diabetes Center, Srinath Sanda, MD. Dr. Sanda received his undergraduate degree at UC San Diego, his medical degree at UC Davis, and completed his residency training in internal medicine and pediatrics at Cedars Sinai Medical Center in LA. He then went on to complete a pediatric endocrinology fellowship at UC San Diego where he worked in the immunology laboratory of Dr. Matthias von Herrath.